首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CeftazidimeAcquired drug resistance: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2025年
/ 2042卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-025-74910-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:111 / 111
相关论文
共 50 条
[41]
KanamycinAcquired drug resistance: case report
Reactions Weekly,
2019,
1765
(1)
: 209
-
209
[42]
PralsetinibAcquired drug resistance: case report
Reactions Weekly,
2022,
1927
(1)
: 451
-
451
[43]
BedaquilineDevelopment of drug resistance: case report
Reactions Weekly,
2023,
1984
(1)
: 109
-
109
[44]
ErlotinibAcquired drug resistance: case report
Reactions Weekly,
2025,
2049
(1)
: 150
-
150
[45]
CrizotinibDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1882
(1)
: 158
-
158
[46]
CrizotinibDevelopment of drug resistance: case report
Reactions Weekly,
2018,
1705
(1)
: 104
-
104
[47]
EmicizumabDevelopment of drug resistance: case report
Reactions Weekly,
2022,
1888
(1)
: 165
-
165
[48]
AfatinibAcquired drug resistance : case report
Reactions Weekly,
2022,
1912
(1)
: 21
-
21
[49]
ImatinibDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1866
(1)
: 209
-
209
[50]
LinezolidDevelopment of drug resistance: case report
Reactions Weekly,
2023,
1983
(1)
: 262
-
262
←
1
2
3
4
5
→